[{"Assets_0_Q3_USD":625086000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-90349000.0,"NetIncomeLoss_1_Q3_USD":-32297000.0,"NetIncomeLoss_3_Q3_USD":-129022000.0,"StockholdersEquity_0_Q3_USD":-17579000.0,"Ticker":"IRWD","CIK":"1446847","name":"IRONWOOD PHARMACEUTICALS INC","OfficialName":"Ironwood Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1913848067.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171102"}]